In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its FDA-approved NexSys PCS system with Persona Technology and the completed transition ...

BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...

Haemonetics (HAE) has drawn attention after recent trading left the shares around $57.76, with negative returns over the month and past 3 months prompting investors to reassess the medical technology ...

TEG brings in former UMG Nashville and Big Machine international strategy exec to accelerate growth of its global live country music division. By Ashley Iasimone Ticketek Entertainment Group (TEG) has ...

Haemonetics Corporation (NYSE:HAE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Haemonetics Corporation (NYSE:HAE) is among the most innovative healthcare stocks. TheFly ...

BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...

BOSTON - Haemonetics Corporation (NYSE:HAE) announced today it received U.S. Food and Drug Administration 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology, ...

2026年3月2日星期一,Haemonetics Corporation (NYSE:HAE)在第47届Raymond James机构投资者年会上进行了展示。首席执行官Chris Simon概述了公司在血浆业务创新方面的战略重点以及介入技术部门的恢复计划。尽管Haemonetics在血浆业务方面表现强劲,但其他领域仍面临挑战,需要进行战略性资本配置和运营调整。

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...